Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update
Ultragenyx Pharmaceutical Inc. NOVATO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercializ...